Display options
Share it on

Curr Treat Options Cardiovasc Med. 2001 Oct;3(5):441-447. doi: 10.1007/s11936-001-0033-6.

Asymptomatic Internal Carotid Artery Origin Stenosis.

Current treatment options in cardiovascular medicine

Karen L. Furie, Mehmet Akif Topcuoglu, Peter J. Kelly, Walter J. Koroshetz, J. Philip Kistler

Affiliations

  1. Stroke Service, Department of Neurology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA. [email protected]

PMID: 11527525 DOI: 10.1007/s11936-001-0033-6

Abstract

Proper therapy for patients with internal carotid artery stenosis requires a precise pathophysiologic diagnosis that includes characterization and localization of ischemic disease of the brain and knowledge of the arterial disease and the collateral cerebral circulation. Noninvasive techniques such as duplex ultrasound and transcranial Doppler, magnetic resonance angiography, and CT angiography allow precise determination of the stroke subtype and parent arterial pathology. Antiplatelet agents prevent the formation of thrombus on carotid artery atherosclerotic plaque. 3-Hydroxy-3-methyglutaryl coenzyme A reductase inhibitors may help stabilize carotid plaques by altering the plaque morphology and reducing inflammation. Carotid endarterectomy, which is the only procedure proven to be beneficial for patients with asymptomatic disease, should be considered primary intervention. Until ongoing trials for interventional procedures are completed, carotid artery angioplasty and stenting should be considered only in patients with contraindications to carotid endarterectomy. It can be argued that an ideal clinical trial in a high-risk population has not yet been completed. This factor has become even more important with the development of stenting procedures. We have long advocated a trial of only treating patients with hemodynamically significant stenotic lesions (70% to 99%).

References

  1. Stroke. 1997 Oct;28(10 ):1966-71 - PubMed
  2. N Engl J Med. 1986 Oct 2;315(14):860-5 - PubMed
  3. JAMA. 1987 Nov 20;258(19):2704-7 - PubMed
  4. Arch Neurol. 1985 Sep;42(9):864-7 - PubMed
  5. N Engl J Med. 1991 Aug 15;325(7):445-53 - PubMed
  6. Can Med Assoc J. 1962 Jun 16;86:1091-9 - PubMed
  7. JAMA. 1981 Apr 10;245(14):1442-5 - PubMed
  8. J Neurosurg. 1974 Sep;41(3):321-31 - PubMed
  9. Ann Neurol. 1979 Sep;6(3):245-52 - PubMed
  10. N Engl J Med. 1980 Apr 10;302(15):838-41 - PubMed
  11. N Engl J Med. 1998 Nov 12;339(20):1415-25 - PubMed
  12. N Engl J Med. 1982 Nov 25;307(22):1388-90 - PubMed
  13. Brain. 2001 Mar;124(Pt 3):457-67 - PubMed
  14. N Engl J Med. 1984 Jul 5;311(1):27-34 - PubMed
  15. JAMA. 1995 May 10;273(18):1421-8 - PubMed
  16. Stroke. 1984 Jul-Aug;15(4):605-13 - PubMed
  17. J Clin Pathol. 2000 Sep;53(9):647-54 - PubMed
  18. N Engl J Med. 1993 Jan 28;328(4):276-9 - PubMed
  19. Neurology. 1996 Mar;46(3):603-8 - PubMed
  20. AMA Arch Neurol Psychiatry. 1951 Mar;65(3):346-77 - PubMed
  21. N Engl J Med. 2000 Jun 8;342(23):1743-5 - PubMed
  22. N Engl J Med. 1991 Aug 15;325(7):505-7 - PubMed
  23. Stroke. 1999 Jul;30(7):1440-3 - PubMed
  24. JAMA. 2000 Apr 26;283(16):2122-7 - PubMed
  25. N Engl J Med. 1981 Aug 20;305(8):417-9 - PubMed
  26. Stroke. 1996 Nov;27(11):1965-9 - PubMed

Publication Types